We are live on ! Find out more
AWGLSCP

ABG-WTT Global Life Science Capital Partners Portfolio holdings

AUM $12.3M
1-Year Est. Return 3.13%
This Fund
S&P 500
This Quarter Est. Return
+5.92%
1 Year Est. Return
-3.13%
3 Year Est. Return
+108.96%
5 Year Est. Return
-90.91%
10 Year Est. Return
–
AUM
$38.3M
AUM Growth
-$5.39M
Cap. Flow
+$1.85M
Cap. Flow %
4.82%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RPID icon
Rapid Micro Biosystems
RPID
+$1.85M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBLL
1
CeriBell Inc
CBLL
$737M
$20.9M 54.54%
1,088,101
– –
CGON icon
2
CG Oncology
CGON
$6.65B
$12.1M 31.67%
495,526
– –
RPID icon
3
Rapid Micro Biosystems
RPID
$87.2M
$4.88M 12.73%
1,848,296
+810,000
+78% +$1.85M
LUNG icon
4
Pulmonx
LUNG
$96.6M
$405K 1.06%
60,204
– –

Similar funds

M
MetLife New York $12.3M AUM 29% 1-Year Est. Return
MAMNY
Marathon Asset Management (New York) New York $12M AUM 8.79% 1-Year Est. Return
VH
Vitol Holding Rotterdam, Netherlands $11.9M AUM 27.28% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
CCM
Crabel Capital Management Los Angeles, California $10.8M AUM 3.34% 1-Year Est. Return
MP
MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return

ABG-WTT Global Life Science Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, ABG-WTT Global Life Science Capital Partners held 4 positions worth $38.3M, down 12% from $43.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG-WTT Global Life Science Capital Partners deployed $1.85M of net new capital in Q1 2025, adding to 1 existing holding.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG-WTT Global Life Science Capital Partners added most to Rapid Micro Biosystems in Q1 2025, an estimated $1.85M increase.
  • ABG-WTT Global Life Science Capital Partners's ten largest holdings make up 100% of its $38.3M portfolio in Q1 2025.
  • ABG-WTT Global Life Science Capital Partners opened 0 new positions and closed 0 in Q1 2025.
  • ABG-WTT Global Life Science Capital Partners's portfolio value fell 12% quarter-over-quarter to $38.3M.

Based on ABG-WTT Global Life Science Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.